Finance News – Gene Therapy
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Investors
Stock
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Bse
Etf
Earnings
Stablecoin
Ipo
Investment
Blockchain
Revenue
Index
Solana
Trade
Sec
Interest Rates
Inflation
Token
Wall Street
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Nse
Profit
Bse Sensex
China
Nifty
Sp 500
Gold
Investor
Tesla
Company
Economy
Cryptos
Equity Derivatives
International Markets
Btc Mining
B2b
Quarterly Losses
Us Chamber Of Commerce
Courses
Airspace
Concession Agreement
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jul 18, 2025
Sarepta shares plunge 40% as future of its gene therapy appears at risk
Sarepta experienced a substantial decline in stock value following reports of a third fatality associated with its gene therapy treatments, raising concerns about the company’s fut...
Read Full Article →
Investopedia • May 27, 2025
Rocket Pharmaceuticals Stock Craters After Gene Therapy Patient Dies
The company's shares experienced a sharp decline following the report of a patient's death linked to its gene therapy treatment, raising concerns among investors about future finan...
Read Full Article →